Kenai Therapeutics
Total Awards:
2
Award Value:
$12,000,000
Institution type:
For profit
Short Name:
Kenai Therapeutics
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Howard J Federoff | A Phase 1 trial of RNDP-001, a dopaminergic progenitor drug product, in idiopathic parkinson’s disease | $8,000,000 |
| Late Stage Preclinical Projects | Howard J Federoff | Allogeneic iPSC derived Dopaminergic Drug Product for Parkinson’s disease | $4,000,000 |
| Total: $12,000,000.00 |
